Acutus Medical Inc Revenue Growth Rates (AFIB), Current and Historic Growth - CSIMarket
CSIMarket
 


Acutus Medical Inc   (AFIB)
 

AFIB's Revenue Growth by Quarter and Year

Acutus Medical Inc 's Revenue results by quarter and year




AFIB Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December 9.01
3rd Quarter September 4.37
2nd Quarter June 3.66
1st Quarter March 2.97
FY 20.01

AFIBs Annual Revenue
Acutus Medical Inc 's Revenue in the fiscal year 2024 $ 20.01 millions
Acutus Medical Inc 's Revenue in the fiscal year 2023 $ 6.86 millions
Acutus Medical Inc 's Revenue in the fiscal year 2022 $ 16.36 millions
Acutus Medical Inc 's Revenue in the fiscal year 2021 $ 17.26 millions
Acutus Medical Inc 's Revenue in the fiscal year 2020 $ 8.46 millions




AFIB Revenue fourth quarter 2024 Y/Y Growth Comment
Acutus Medical Inc achieved in the fourth quarter 2024, above Company average Revenue surge of 283.57% year on year, to $ 9.01 millions.

Looking into fourth quarter 2024 results within Medical Equipment & Supplies industry 112 other companies have achieved higher Revenue growth. While Acutus Medical Inc ' s Revenue doubling of 283.57% ranks overall at the positon no. 2192 in the fourth quarter 2024.




AFIB Revenue ( Y/Y Growth %) 2024
2023 2022 2021
4th Quarter December 283.57 % -52.62 % 13.76 % 69.65 %
3rd Quarter September -5.82 % 27.47 % -20.87 % 45.11 %
2nd Quarter June - - -13.38 % 316.81 %
1st Quarter March -28.78 % 13.32 % 2.51 % 127.22 %
FY   79.34 % -31.78 % -5.21 % -

Financial Statements
Acutus Medical Inc 's fourth quarter 2024 Revenue $ 9.01 millions AFIB's Income Statement
Acutus Medical Inc 's fourth quarter 2023 Revenue $ 2.35 millions Quarterly AFIB's Income Statement


AFIB Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
4th Quarter December 106.27 % -49.35 % 36.26 % -5.22 %
3rd Quarter September 19.4 % - -10.78 % -2.34 %
2nd Quarter June 23.23 % - 10.87 % 31.2 %
1st Quarter March 26.38 % -15.93 % -15.6 % 39.69 %
FY (Year on Year)   79.34 % -31.78 % -5.21 % -




Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #113
Healthcare Sector #336
Overall #2192

Revenue Y/Y Growth Statistics
High Average Low
408.38 % 153.89 % -5.17 %
(Jun 30 2022)   (Mar 31 2023)
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #113
Healthcare Sector #336
Overall #2192
Revenue Y/Y Growth Statistics
High Average Low
408.38 % 153.89 % -5.17 %
(Jun 30 2022)   (Mar 31 2023)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Acutus Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
179.81 % 11.28 % -100 %
(Sep 30 2020)  


AFIB's IV. Quarter Q/Q Revenue Comment
Acutus Medical Inc achieved in the IV. Quarter 2024 above company average sequential Revenue doubling of 106.27%, to $ 9.01 millions, from $4.37 millions in the third quarter.
AFIB is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Acutus Medical Inc 's Revenue growth quarter on quarter, overall rank is 218.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #10
Healthcare Sector #61
Overall #218
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #10
Healthcare Sector #61
Overall #218
Revenue Q/Q Growth Statistics
High Average Low
179.81 % 11.28 % -100 %
(Sep 30 2020)  


AFIB's IV. Quarter Q/Q Revenue Comment
Acutus Medical Inc achieved in the IV. Quarter 2024 above company average sequential Revenue doubling of 106.27%, to $ 9.01 millions, from $4.37 millions in the third quarter.
AFIB is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Acutus Medical Inc 's Revenue growth quarter on quarter, overall rank is 218.


Acutus Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2024)
12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
Cumulative Revenue 12 Months Ending $ 20.01 $ 13.35 $ 13.62 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) 49.94 % -1.99 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 2320 # 1999 # 0 # 1187 # 2728


Cumulative Revenue growth Comment
Acutus Medical Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 283.57% year on year, to $ 20 millions if the fiscal year would have ended in Dec 31 2024.
Acutus Medical Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Sep 30 2024. And, Acutus Medical Inc realized the fastest Revenue growth, in Medical Equipment & Supplies industry.
But from twelve months ended Sep 30 2024 rise was beneth at 49.94 % from $13.35 millions achieved in the period from Sep 30 2024 to Dec 31 2023.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at153.89%.
The momentum is even more impressive from twelve months ended Sep 30 2024 exhibited at 49.94 % increase from $13.35 millions in the period from Sep 30 2024 to Dec 31 2023.

Acutus Medical Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 117
Sector # 349
S&P 500 # 2320
Cumulative Revenue growth Comment
Acutus Medical Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 283.57% year on year, to $ 20 millions if the fiscal year would have ended in Dec 31 2024.
Acutus Medical Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Sep 30 2024. And, Acutus Medical Inc realized the fastest Revenue growth, in Medical Equipment & Supplies industry.
But from twelve months ended Sep 30 2024 rise was beneth at 49.94 % from $13.35 millions achieved in the period from Sep 30 2024 to Dec 31 2023.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at153.89%.
The momentum is even more impressive from twelve months ended Sep 30 2024 exhibited at 49.94 % increase from $13.35 millions in the period from Sep 30 2024 to Dec 31 2023.

Acutus Medical Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 117
Sector # 349
S&P 500 # 2320




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AFIB's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2024
Ss Innovations International Inc469.01%$ 469.009 millions
Arcutis Biotherapeutics Inc 427.58%$ 427.577 millions
Tarsus Pharmaceuticals Inc 407.86%$ 407.862 millions
Alaunos Therapeutics Inc 400.00%$ 400.000 millions
Bluebird Bio Inc 391.72%$ 391.716 millions
Vivosim Labs Inc 380.00%$ 380.000 millions
Anaptysbio Inc 378.77%$ 378.767 millions
Xoma Royalty Corporation375.40%$ 375.396 millions
Insight Molecular Diagnostics Inc 373.25%$ 373.248 millions
Vaxart Inc 367.95%$ 367.951 millions
Capforce Inc 367.41%$ 367.413 millions
Novo Nordisk A343.27%$ 343.275 millions
Harvard Apparatus Regenerative Technology Inc 309.52%$ 309.524 millions
Acutus Medical Inc 283.90%$ 283.901 millions
Sangamo Therapeutics Inc 269.78%$ 269.785 millions
Alector Inc 257.08%$ 257.077 millions
Ardelyx inc 237.95%$ 237.948 millions
Bridgebio Pharma Inc 237.08%$ 237.077 millions
Neuroone Medical Technologies Corp234.90%$ 234.902 millions
Immuron Limited192.95%$ 192.955 millions
Wave Life Sciences Ltd 188.23%$ 188.230 millions
Protagonist Therapeutics inc 184.40%$ 184.397 millions
Icad Inc179.81%$ 179.811 millions
Femasys Inc 172.90%$ 172.898 millions
Vsee Health Inc 170.28%$ 170.277 millions
Nexgel Inc 157.86%$ 157.856 millions
Opus Genetics Inc 154.41%$ 154.406 millions
American Shared Hospital Services154.30%$ 154.303 millions
Verve Therapeutics Inc 154.28%$ 154.277 millions
Ensysce Biosciences Inc 153.12%$ 153.122 millions


About Acutus Medical Inc Revenue Growth Rates (AFIB), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Acutus Medical Inc (CIK 1522860).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-25-014559
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Acutus Medical Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.